Search
Search
Antioxidants in the brain linked to improved treatment results in patients with psychosis
LONDON, ON – New research from Western University and Lawson Health Research Institute demonstrates that increased antioxidant levels in the brain may improve outcomes of early intervention in psychosis. In the paper published in Nature Molecular Psychiatry, the research team found that patients with higher levels of an antioxidant called glutathione responded more quickly to medication for psychosis and had improved outcomes.
“Once patients with psychosis start treatment, some get better in weeks while it can take months for others. We wanted to see if we could understand and influence this disparity,” said Dr. Lena Palaniyappan, Associate Professor at Western’s Schulich School of Medicine & Dentistry and Scientist at Lawson Health Research Institute. “We found that the amount of antioxidants that patients have in their brains predicts the time that it takes for them to respond to treatment.”
Previous research has shown that patients who respond early to antipsychotic medications have better overall outcomes in terms of symptoms and daily functioning. The research team has estimated that a 10 per cent increase in antioxidants could lead to a reduction in length of hospital stay by at least seven days.
“This study demonstrates that if we can find a way to boost the amount of antioxidants in the brain, we might be able to help patients transition out of hospital more quickly, reduce their suffering more quickly and help them return earlier to their work and studies,” said Dr. Palaniyappan who is also the Tanna Schulich Endowed Chair in Neuroscience and Mental Health at Western.
Antioxidant levels in the brain vary naturally from person to person and those variations can be attributed to lifestyle choices like exercise and diet. There are also ways to pharmaceutically boost these levels. A supplement called N-Acetyl Cysteine (NAC) as well as broccoli extracts can increase the brain’s antioxidants if given over a long period of time.
Dr. Palaniyappan and his team used high-field MRI imaging to examine antioxidant levels in the brains of 37 new patients to the Prevention and Early Intervention for Psychoses Program (PEPP) at London Health Sciences Centre. Antioxidant levels were studied prior to beginning treatment for psychosis and followed up for six months post-treatment.
The MRI scans were acquired at Western’s Centre for Functional and Metabolic Mapping at the Robarts Research Institute with the support of Western's BrainsCAN and the Canadian Institutes of Health Research.
-30-
Lawson Health Research Institute is one of Canada’s top hospital-based research institutes, tackling the most pressing challenges in health care. As the research institute of London Health Sciences Centre and St. Joseph’s Health Care London, our innovation happens where care is delivered. Lawson research teams are at the leading-edge of science with the goal of improving health and the delivery of care for patients. Working in partnership with Western University, our researchers are encouraged to pursue their curiosity, collaborate often and share their discoveries widely. Research conducted through Lawson makes a difference in the lives of patients, families and communities around the world. To learn more, visit www.lawsonresearch.ca.
Western delivers an academic experience second to none. Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities. Our research excellence expands knowledge and drives discovery with real-world application. Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.
The Schulich School of Medicine & Dentistry at Western University is one of Canada’s preeminent medical and dental schools. Established in 1881, it was one of the founding schools of Western University and is known for being the birthplace of family medicine in Canada. For more than 130 years, the School has demonstrated a commitment to academic excellence and a passion for scientific discovery.
Senior Media Relations Consultant
Communications & Public Engagement
T: 519-685-8500 ext. 73502
Celine.zadorsky@lhsc.on.ca
Antioxidants in the brain linked to improved treatment results in patients with psychosis
Once patients with psychosis start treatment, some get better in weeks while it can take months for others.
“We wanted to see if we could understand and influence this disparity,” said Dr. Lena Palaniyappan, Associate Professor at Western’s Schulich School of Medicine & Dentistry and Scientist at Lawson Health Research Institute who is looking at chemicals in the brain with the aim of speeding up the time it takes a patient to respond to medication for psychosis.
The research team from Lawson and Schulich Medicine & Dentistry studied antioxidant levels in the brain, and found that these chemicals which rid the body of normal metabolic biproducts called free radicals, may improve outcomes of early intervention in psychosis. They looked specifically at an area of the brain called Cingulate Cortex which is well connected to a network of regions that play a major role in generating symptoms of psychosis.
The study, published in Nature Molecular Psychiatry, showed that patients with higher levels of an antioxidant called glutathione responded more quickly to medication for psychosis and had improved outcomes. They estimated that a 10 per cent increase in antioxidants could lead to a reduction in length of hospital stay by at least seven days.
“This study demonstrates that if we can find a way to boost the amount of antioxidants in the brain, we might be able to help patients transition out of hospital more quickly, reduce their suffering more quickly and help them return earlier to their work and studies,” said Dr. Palaniyappan who is also the Tanna Schulich Endowed Chair in Neuroscience and Mental Health at Western.
Antioxidant levels in the brain vary naturally from person to person and those variations can be attributed to lifestyle choices like exercise and diet. There are also ways to pharmaceutically boost these levels. A supplement called N-Acetyl Cysteine (NAC) as well as broccoli extracts can increase the brain’s antioxidants if given over a long period of time.
Dr. Palaniyappan and his team in collaboration with Dr. Jean Theberge at Lawson Imaging used high-field MRI imaging to examine antioxidant levels in the brains of 37 new patients to the Prevention and Early Intervention for Psychoses Program (PEPP) at London Health Sciences Centre. Antioxidant levels were studied prior to beginning treatment for psychosis and followed up for six months post-treatment.
The MRI scans were acquired at Western’s Centre for Functional and Metabolic Mapping at the Robarts Research Institute with the support of Western's BrainsCAN and the Canadian Institutes of Health Research.
Archive: Lawson Impact Awards
The Lawson Impact Awards recognized excellence in academics, leadership, training, operations, industry and innovation.
Past award recipients by year can be found in the webpages below:
- Celebrating health research excellence with the 2023 Lawson Impact Awards
- Lawson Impact Awards: Strategic Research Fund Award 2022
- Lawson Impact Awards Innovation Award: Dr. Dalton Wolfe
- Lawson Impact Awards Scientist of the year award: Dr. Douglas Fraser
- Lawson Impact Awards Dr. Joseph Gilbert Research Contribution of the year award: Dr. Daniel Hardy
- Lawson Impact Awards Community Partner of the Year Award: Archie Verspeeten
- Lawson Impact Awards Community Partner of the Year Award: Dr. Joseph Rea
- Lawson Impact Awards Staff Award of Excellence: Dr. Jeff Weiler
- 2019 Lawson Impact Awards honours research excellence and innovation
- 2018 Lawson Impact Awards honours research excellence
- 2017 Lawson Impact Awards Celebrates Research making a difference
Are you passionate about population health?
Applications are being accepted for the ICES Faculty Scholars Program’s fourth training cycle, 2019-2021. It is a two-year, part-time learning opportunity for Ontario-based academic faculty who wish to develop their skills in population health research.
The program provides access to linkable health administrative databases housed at ICES and fosters the development of interdisciplinary research collaborations among peers and experts across the ICES network.
"The Faculty Scholars Program through ICES gives individuals passionate about population health and health services research the data and expertise to make better policy and stronger health care for healthier people,” says Dr. Amit Garg, Lawson Scientist and ICES Western Site Director and Program Lead.
“Past Scholars have made many meaningful contributions and helped feature London as a Canadian leader in today's knowledge-based economy. We can’t wait to see what the new Scholars come up with during their time with the program."
Since 2013, over 40 researchers have been trained from a variety of clinical and non-clinical backgrounds including anaesthesia and perioperative medicine, clinical neurological sciences, epidemiology and biostatistics, family medicine, medicine, nursing, obstetrics and gynaecology, oncology, otolaryngology, paediatrics, psychiatry and surgery. They have won national awards and have published a number of peer-reviewed journal articles as first authors.
To be considered for the 2019-2021 cycle of the Faculty Scholars Program, you must hold an appointment of assistant professor or higher at a recognized Ontario university, a master’s or doctoral degree with a focus on quantitative research methods, and a strong desire to become an ICES Scientist.
Applications for the 2019–2021 program will be accepted until January 18, 2019. Any questions regarding the program, applications or eligibility can be directed to facultyscholars@ices.on.ca.
Go to the ICES website for more information on the ICES Faculty Scholars Program.